Management of Cancer-Associated Venous Thromboembolism in the Emergency Department

Ann Emerg Med. 2017 Jun;69(6):768-776. doi: 10.1016/j.annemergmed.2016.12.003. Epub 2017 Feb 4.

Abstract

Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Contraindications
  • Emergency Service, Hospital*
  • Guidelines as Topic
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Neoplasms / complications*
  • Practice Guidelines as Topic*
  • Recurrence
  • Risk Factors
  • Secondary Prevention / methods
  • Venous Thromboembolism / drug therapy*
  • Venous Thromboembolism / prevention & control
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Vitamin K